[{"address1": "601 Brickell Key Drive", "address2": "Suite 1000", "city": "Miami", "state": "FL", "zip": "33131", "country": "United States", "phone": "305-203-2034", "website": "https://www.smmttx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis, as well as in Phase III clinical trials for the treatment of non-small lung cancer. The company was founded in 2003 and is headquartered in Miami, Florida.", "fullTimeEmployees": 159, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert W. Duggan", "age": 79, "title": "Co-CEO & Executive Chairman", "yearBorn": 1945, "fiscalYear": 2024, "totalPay": 158613, "exercisedValue": 0, "unexercisedValue": 1133457}, {"maxAge": 1, "name": "Dr. Mahkam  Zanganeh D.D.S., M.B.A.", "age": 54, "title": "Co-CEO, President & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1161021, "exercisedValue": 0, "unexercisedValue": 128563160}, {"maxAge": 1, "name": "Prof. Dame Kay Davies DBE, FRS CBE", "age": 73, "title": "Co-Founder, Chairman of Scientific Advisory Board and Scientific Advisor", "yearBorn": 1951, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dave  Gancarz", "title": "Chief Business & Strategy Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Fong  Clow", "title": "Chief Biometrics Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Shelley D. Spray", "age": 59, "title": "Chief Education & Brand Officer", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Urte  Gayko Ph.D.", "age": 53, "title": "Chief Regulatory, Quality & Pharmacovigilance Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Allen S. Yang M.D., Ph.D.", "age": 56, "title": "Chief Medical Officer", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Laura Q. M. Chow M.D.", "title": "Senior Vice President of Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  LaCaze", "title": "Chief Commercial Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 8, "compensationRisk": 10, "shareHolderRightsRisk": 5, "overallRisk": 10, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 24.29, "open": 24.48, "dayLow": 23.96, "dayHigh": 25.79, "regularMarketPreviousClose": 24.29, "regularMarketOpen": 24.48, "regularMarketDayLow": 23.96, "regularMarketDayHigh": 25.79, "payoutRatio": 0.0, "beta": -0.948, "forwardPE": -67.18553, "volume": 1496219, "regularMarketVolume": 1496242, "averageVolume": 4038509, "averageVolume10days": 7532200, "averageDailyVolume10Day": 7532200, "bid": 18.4, "ask": 30.75, "bidSize": 2, "askSize": 2, "marketCap": 18960633856, "fiftyTwoWeekLow": 2.1, "fiftyTwoWeekHigh": 36.91, "fiftyDayAverage": 21.7021, "twoHundredDayAverage": 19.1929, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 17684490240, "profitMargins": 0.0, "floatShares": 116175230, "sharesOutstanding": 742665984, "sharesShort": 25090847, "sharesShortPriorMonth": 21221508, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.033800002, "heldPercentInsiders": 0.84309995, "heldPercentInstitutions": 0.12973, "shortRatio": 7.15, "shortPercentOfFloat": 0.2151, "impliedSharesOutstanding": 742665984, "bookValue": 0.464, "priceToBook": 55.022633, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -240755008, "trailingEps": -0.34, "forwardEps": -0.38, "enterpriseToEbitda": -75.136, "52WeekChange": 4.08159, "SandP52WeekChange": 0.08001411, "quoteType": "EQUITY", "currentPrice": 25.5305, "targetHighPrice": 43.87121, "targetLowPrice": 29.912909, "targetMeanPrice": 37.270176, "targetMedianPrice": 37.398426, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 8, "totalCash": 361315008, "totalCashPerShare": 0.487, "ebitda": -235366000, "totalDebt": 6450000, "quickRatio": 10.36, "currentRatio": 10.63, "debtToEquity": 1.873, "returnOnAssets": -0.525, "returnOnEquity": -1.23928, "freeCashflow": -104799248, "operatingCashflow": -173140000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SMMT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 5.1070375, "exchange": "NGM", "messageBoardId": "finmb_11611587", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "longName": "Summit Therapeutics Inc.", "shortName": "Summit Therapeutics Inc.", "marketState": "REGULAR", "corporateActions": [], "regularMarketTime": 1746724106, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1425565800000, "regularMarketPrice": 25.5305, "regularMarketChange": 1.2404995, "regularMarketDayRange": "23.96 - 25.79", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 4038509, "fiftyTwoWeekLowChange": 23.4305, "fiftyTwoWeekLowChangePercent": 11.157381, "fiftyTwoWeekRange": "2.1 - 36.91", "fiftyTwoWeekHighChange": -11.379499, "fiftyTwoWeekHighChangePercent": -0.30830398, "fiftyTwoWeekChangePercent": 408.15903, "earningsTimestamp": 1746130140, "earningsTimestampStart": 1754310600, "earningsTimestampEnd": 1754656200, "earningsCallTimestampStart": 1746131400, "earningsCallTimestampEnd": 1746131400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.34, "epsForward": -0.38, "epsCurrentYear": -0.298, "priceEpsCurrentYear": -85.67282, "fiftyDayAverageChange": 3.8283997, "fiftyDayAverageChangePercent": 0.17640688, "twoHundredDayAverageChange": 6.3376007, "twoHundredDayAverageChangePercent": 0.33020547, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Summit Therapeutics plc", "nameChangeDate": "2025-05-07", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "displayName": "Summit Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-08"}]